Stryker signs definitive agreement to acquire ZuriMED

Niederer Kraft Frey advised the shareholders of ZuriMED Technologies AG (“ZuriMED”), comprising more than 100 institutional and private investors, surgeons, and scientists, on the sale of ZuriMED to Stryker. This transaction is subject to customary closing conditions.

ZuriMED is the developer of the FiberLocker® System, a commercialized technology offering a novel approach to rotator cuff augmentation designed for increased biomechanical strength, addressing a key clinical failure mode in rotator cuff repair. ZuriMED is part of the Swiss health cluster, surrounded by world-leading universities and orthopedic healthcare institutions.

The NKF team was led by Corporate/M&A partners Patrik Peyer and Roman Sturzenegger, working with partners Nicolas Birkhäuser (Competition) and Janine Reudt-Demont (IP/Life Sciences & Healthcare), senior associate Alexander Göbel (Corporate/M&A), associates Lukas Poschung (Competition), Melchior Ebener and Anastasia Herger, as well as junior associate Nora Arpagaus (all Corporate/M&A).

ZuriMED’s shareholders were further advised by Mintz on U.S. law matters, and by PwC on tax matters. Deutsche Bank acted as financial advisor.